Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmedeo Resources Regulatory News (AMED)

  • There is currently no data for AMED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company-Amend

3 Apr 2006 17:17

Creon Corporation PLC03 April 2006 Creon Corporation PLC (the 'Company') Amendment to Notifiable Interest In amendment to the Notifiable Interest announcement released on 29 March 2006at 07:00 am under RNS no. 5591A, Creon Corporation PLC announces that it received notice on 3 April 2006 from Newton Nominees Ltd advising that on 23 March 2006 it acquired 871,110 ordinary shares of 1p each in the Company at a price of 50p per share. Newton Nominees Ltd now holds a total of 2,371,110 ordinary shares in the capital of the Company, representing 23.63% of the issued ordinary share capital of the Company. For further information, please contact: Nairn Black, Noble & Company Limited 0131 225 9677 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jan 20054:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.